Jiangsu Hengrui Pharmaceuticals (600276.SH) has obtained the notification letter for drug clinical trial approval.
Hengrui Medicine (600276.SH) announced that recently, the company and its subsidiaries Shanghai Hengrui Medicine Co., Ltd., Shanghai Shengdi Medicine Co., Ltd., and Suzhou Shengdi BioPharmaceutical Co., Ltd. received the approval notification for clinical trial batches of SHR-4375 injection, Atezolizumab injection, SHR-8068 injection, Bevacizumab injection, HRS-4642 injection, and SHR-9839 (sc) injection issued by the National Medical Products Administration ("NMPA"). Clinical trials will be conducted in the near future.
Jiangsu Hengrui Pharmaceuticals (600276.SH) announced that recently, the company and its subsidiaries Shanghai Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai Shengdi Pharmaceutical Co., Ltd., and Suzhou Shengdiya Biopharmaceutical Co., Ltd. have received the approval and issuance of the "Drug Clinical Trial Approval Notice" from the National Medical Products Administration ("NMPA") for SHR-4375 injection, Adabrein single-dose injection, SHR-8068 injection, Bevacizumab injection, HRS-4642 injection, and SHR-9839(sc) for injection. Clinical trials will be conducted soon.
Specifically, a multicenter, open-label Phase I/II clinical study on the safety, tolerability, and effectiveness of SHR-4375 injection in combination with anti-tumor therapy in patients with advanced solid tumors.
Related Articles

Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


